This disclosure relates generally to compounds and compositions comprising one or more diphenylethylene, diphenylethylyne, and azobenzene analogs. These compounds are useful for treating diseases associated with NF-kB and p53 activity, such as cancer and inflammatory disease.
这份披露通常涉及包含一种或多种
二苯乙烯、二
苯乙炔和
偶氮苯类似物的化合物和组合物。这些化合物对治疗与NF-kB和p53活性相关的疾病,如癌症和炎症性疾病,具有用处。